Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of Fatty Acid Oxidation Defects in Insulin Sensitivity
NCT02517307Completed
- Sponsor
- Oregon Health & Science University
- Start
- Feb 2016
- Primary completion
- Jan 2021
- Countries
- 1
01
Overview
Randomised, open-label trial (4 arms), sponsored by Oregon Health & Science University. Primary endpoint: Glucose Disposal Rate. Started Feb 2016; status: completed.
Beyond the preview
Go deeper on NCT02517307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02517307.